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Impact of Patient Selection Criteria on Prevalence
Estimates and Prevalence of Diagnosed Dementia in
a Medicaid Population
Murtuza F. Bharmal, MS, PhD,*w Michael Weiner, MD,z Laura P. Sands, PhD,y
Huiping Xu, MS,J Bruce A. Craig, PhD,J and Joseph Thomas, III, MS, PhDz
Objectives: This study estimated the prevalence of diagnosed
dementia among Indiana Medicaid beneficiaries in 2004. The
dependence of prevalence estimates upon use of several patient
selection criteria to identify patients with dementia also was
evaluated.
Methods: Indiana Medicaid claims data were analyzed for the
period July 1, 2002 to December 31, 2004. An expert panel
survey was conducted to assess perceived specificity of ICD
codes used in previous studies to define dementia. Prevalence
estimates were calculated with varying levels of each selection
criteria, that is, ICD code set, interval of data examined, and
number of occurrences of dementia-related claims. To assess
specificity and sensitivity of the dementia patient selection
criteria, Minimum Data Set data for a subset of beneficiaries
that resided in a nursing home any time in 2004 were examined.
Results: Depending on the patient selection criteria used,
estimates of prevalence of diagnosed dementia for individuals
40 years old or older varied from 7.7% to 15.3%, whereas
prevalence estimates for individuals 60 years old or older varied
from 14.5% to 26.6%. When the following selection criteria
were used: (1) occurrence of one or more dementia-related
claims, (2) the expert panel ICD set, and (3) up to 30 months of
data for defining dementia, the prevalence estimates in the
Indiana Medicaid population were 10.9% for individuals 40
years old or older and 20.3% for individuals 60 years old or
older.
Conclusions: Careful selection of claims-based criteria for
identifying patients with dementia is important because the
criteria may affect estimates by 100%. Prevalence of diagnosed
dementia among Indiana Medicaid beneficiaries was 3 to 4 times
higher than the reported prevalence from a decade ago in
Medicaid populations of other states, even when the same
patient selection criteria were used. A number of factors beyond
increased occurrence of the disease including increased screen-
ing, greater likelihood of recording dementia codes in claims, or
other factors may be responsible. The combination of patient
selection criteria used in this study had good sensitivity,
specificity, and accuracy when compared with Minimum Data
Set data.
Key Words: dementia, Alzheimer disease, Medicaid, prevalence,
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(Alzheimer Dis Assoc Disord 2007;21:92–100)
Ten years ago, the prevalence of diagnosed dementia inthe California Medicaid and Georgia Medicaid
populations exceeded 4%.1,2 To our knowledge, current
estimates of diagnosed dementia for the Medicaid
population have not been published but are likely to be
much higher, in part because of greater attention to
screening and evaluation for dementia.3,4 Current pre-
valence estimates of diagnosed dementia among Medicaid
recipients are important to Medicaid programs for a
number of reasons.5,6 Medicaid spending has recently
seen a sharp increase, which has often placed Medicaid at
the center of governmental budget discussions, at both
federal and state levels.7 In 1995, the annual excess
spending by California Medicaid for patients with
dementia was estimated at approximately $200 million,
with most of those costs attributed to higher rates of
institutionalization.1 Persons with dementia are at 5 times
the risk of institutionalization as those without dementia,
and nearly half of the costs of nursing-home care are
borne by state governments through Medicaid pro-
grams.8,9
Administrative claims data are a widely used cost-
effective resource for epidemiologic and health services
research including estimating prevalence of diagnosed
disease in specific populations.1,2,4 However, administra-
tive claims-based analyses of conditions such as dementiaCopyright r 2007 by Lippincott Williams & Wilkins
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depend on many factors including reimbursement policies
and the variable nature of diagnostic coding. To date,
claims-based studies of prevalence of diagnosed dementia
have used a wide variety of diagnosis codes, with limited
consensus or specificity testing. For example, using the
International Classification of Diseases (ICDs), 9th
revision, Clinical Modification, studies of dementia have
included codes for unspecified psychotic condi-
tions1,2,10–14 and senility,1,2,10,13,15 though these terms
themselves do not denote dementia.
Other patient selection factors, such as the interval
of data examined, age threshold for inclusion, and
number of occurrences of dementia-related claims for
inclusion, may substantially alter prevalence estimates.
These important factors also have varied across stu-
dies.1,2,10–20 It is important to understand the effect of
using various criteria on estimates, because the allocation
of public resources for the care of persons with dementia
depends on accurate estimates of prevalence.
The objectives of this study were to estimate the
prevalence of diagnosed dementia among Indiana Medi-
caid beneficiaries in 2004 and to describe the dependency
of the estimates upon specific patient selection criteria
used in previous studies. We hypothesized that prevalence
of diagnosed dementia would be significantly higher than
seen in other Medicaid studies from a decade ago, and
that factors such as increasing age threshold, increasing
the number of diagnosis codes used to determine
dementia, and lengthening the time interval of claims
data examined to detect a diagnosis of dementia would
increase the estimated prevalence of diagnosed dementia
significantly.
METHODS
Research Design and Data Sources
The study was conducted with Medicaid eligibility
and claims data maintained by the Indiana Family and
Social Services Administration. The data files contain a
unique, encrypted identifier that permits Indiana Medi-
caid recipients to be tracked over time. Detailed data for
all claims with a date of service between July 1, 2002 and
December 31, 2004 were extracted for all persons who
were Medicaid eligible for at least 1 month in 2004. Data
elements extracted from the eligibility files and the claim
files included details on beneficiaries’ age, sex, race,
eligibility category, outpatient service use, institutional
service (hospital and nursing home) use, and other
medical service use. Outpatient and institutional service
claims contained dates of service, the primary diagnosis,
up to 3 secondary diagnoses (ICD codes), and the Indiana
Medicaid paid amounts.
Minimum Data Set (MDS) data also was extracted
for beneficiaries who resided in nursing homes any time in
2004 to determine whether each individual was designated
as having dementia. That information from the MDS was
used to assess specificity and sensitivity of the dementia
patient selection criteria. The study was approved by the
Institutional Review Board of Purdue University.
Identification of Patients With Dementia
Review of Dementia-related ICD Codes Used in
Previous Studies
A literature search was conducted using MEDLINE
and International Pharmaceutical Abstracts searches
(1966 to present) to identify studies that had used medical
claims data and ICD codes to identify patients
with dementia. A keyword search was conducted using
a combination of the terms ‘‘dementia’’ and either
‘‘claims’’ or ‘‘administrative data.’’ Over 140 articles were
retrieved.
For the current analysis, articles that had used ICD
codes to identify ‘‘dementia patients’’ or ‘‘Alzheimer
disease and related dementia patients’’ from medical
claims were reviewed. Studies that focused on only one
specific type of dementia were excluded from the analysis.
A total of 11 studies were identified that had used ICD
codes to identify patients with Alzheimer disease or
related dementias from medical claims.1,2,10–18 A list of
dementia-related ICD codes used in the 11 studies is
provided in Table 1. There was substantial variation in
the ICD codes used across studies. None of the studies
used all of the 47 ICD codes listed to identify patients
with dementia. The list of all 47 ICD codes was termed
the ‘‘collective ICD set’’ for the purpose of this manu-
script.
Expert Panel Survey
To assess perceived specificity among clinicians of
each of the ICD codes in the collective ICD set for
identifying patients with dementia, we surveyed an expert
panel of health professionals in Indiana with experience
evaluating or treating patients with dementia. The panel,
which included 3 geriatricians, a neurologist, a psychia-
trist, and a neuropsychologist, rated on a 4-point scale
(1= ‘‘Rarely,’’ 2= ‘‘Occasionally,’’ 3= ‘‘Frequently,’’
4= ‘‘Almost Always’’) how often dementia occurs with
each diagnosis. We specified a priori that to qualify as a
specific diagnosis, at least 5 of the 6 professionals had to
provide a rating of ‘‘Almost Always’’ or ‘‘Frequently.’’
This general threshold, on the basis of the content validity
literature, has been validated and is widely used in expert
panel surveys.21 The ICD codes that met the a priori
criteria as being perceived specific for dementia on the
basis of at least 5 of the 6 experts saying ‘‘Almost
Always’’ or ‘‘Frequently,’’ are highlighted in bold font
and have an asterisk beside them in the ‘‘Expert Panel’’
column of Table 1. Twenty-six of the ICD codes were
indicated by the expert panel as being specific for
identifying patients with dementia and were termed the
‘‘expert panel ICD set’’ for the purpose of this manu-
script.
Evaluation of the Effect of Patient Selection
Criteria on Prevalence Estimates
We assessed whether prevalence estimates of diag-
nosed dementia among Indiana Medicaid beneficiaries
differed depending on each of the following factors: (1)
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using the collective ICD set versus the expert panel ICD
set; (2) using a minimum number of dementia-related
claims of 1 versus 2; and (3) using up to 30 months (July
1, 2002 to December 31, 2004) versus up to 12 months of
data (January 1, 2004 to December 1, 2004) to detect a
diagnosis of dementia. The 3 factors were studied for
individuals age 40 years or older and individuals age 60
years or older.
Specificity and Sensitivity of the Dementia
Patient Selection Criteria
To assess specificity and sensitivity of the combina-
tion of patient selection criteria used in the current study
for identifying patients with dementia, dementia classifi-
cations on the basis of the selection criteria were
compared with MDS information on whether individuals
were designated as having dementia for individuals who
TABLE 1. ICD-9 Codes Used to Identify Patients With Dementia From Medical Claims Data in Previous Studies and Indicated as
Specific for Dementia Diagnosis by the Expert Panel Study
Studyw
Description ICD-9-CM Expert Panel* A1 B2 C17 D10 E11 F12 G13 H16 I15 J18 K14
Senile and presenile organic psychotic conditions 290 — — O — O O O O — — — —
Senile dementia, uncomplicated 290.0 * O O O O O O O O O — O
Presenile dementia 290.1 * O O O O O O O O O — O
Presenile dementia, uncomplicated 290.10 * O O — O O O O O O O O
Presenile dementia with delirium 290.11 * O O O O O O O O O — O
Presenile dementia with delusional features 290.12 * O O O O O O O O O — O
Presenile dementia with depressive features 290.13 * O O O O O O O O O — O
Senile dementia with delusional features 290.20 * O O — O O O O O O — O
Senile dementia with delusional or depressive features 290.2 * O O O O O O O O — — O
Senile dementia with depressive features 290.21 * O O O O O O O O O — O
Senile dementia with delirium 290.3 * O O O O O O O O O — O
Arteriosclerotic dementia 290.4 * O O — O O O O — — O O
Arteriosclerotic dementia, uncomplicated 290.40 * O O — O O O O — O — O
Arteriosclerotic dementia with delirium 290.41 * O O — O O O O — O — O
Arteriosclerotic dementia with delusional features 290.42 * O O — O O O O — O — O
Arteriosclerotic dementia with depressive features 290.43 * O O — O O O O — O — O
Other specified senile psychotic condition 290.8 — — — O O O O — — — O —
Unspecified senile psychotic condition 290.9 — O O — O O O O — — — O
Alcohol amnestic syndrome 291.1 — — — — — — — — — — — O
Other alcoholic dementia 291.2 * — — — O — — O — — — O
Drug-induced dementia 292.82 — — — — O — — O — — — O
Other organic psychotic condition 294 — — — — — O — — — — — —
Amnestic syndrome (Korsakoff’s psychosis or
syndrome, nonalcoholic)
294.0 — — — — — O — — — O — —
Dementia in conditions classified elsewhere 294.1 * — — — O O — O — O O O
Dementia in conditions classified elsewhere
without behavioral disturbance
294.10 * — — — — O — — — — — O
Dementia in conditions classified elsewhere
with behavioral disturbance
294.11 * — — — — O — — — — — O
Other specified organic brain syndromes (chronic) 294.8 — — — — O O — O — O O —
Other unspecified organic brain syndrome 294.9 — O — — — O — — — — — —
Jakob-Creutzfeldt disease 046.1 * — — — — — — — — — — O
Subacute sclerosing panencephalitis 046.2 — — — — — — — — — — — O
Other cerebral degenerations 331 — — O — — O O — — — — —
Alzheimer disease 331.0 * O O O O O O O O O O O
Frontotemporal dementia 331.1 * — O — O O O O — O O O
Pick disease 331.11 * — O — — O O — — — — —
Other frontotemporal dementia 331.19 * — O — — O O — — — — —
Senile degeneration of brain 331.2 * O O — O O O O — O O —
Communicating hydrocephalus 331.3 — — — — — O O — — — — —
Obstructive hydrocephalus 331.4 — — — — — O O — — — — —
Cerebral degeneration in diseases classified elsewhere 331.7 — — — — — O O — — O O —
Other cerebral degeneration 331.8 — — O — — O O — — — — —
Reye syndrome 331.81 — — — — — O O — — — — —
Dementia with Lewy bodies 331.82 * — O — — O O — — — — —
Cerebral degeneration, other 331.89 — O O — — O O — — — — —
Cerebral degeneration, unspecified 331.9 — O O — — O O — — — — —
Huntington chorea 333.4 — — — — — — — — — — — O
Senility 797 — O O — O — — O — O — —
*ICD codes that were rated as specific for dementia diagnosis by the expert panel are in bold and have an asterisk beside them.
wSuperscript numbers are the corresponding references for each study as listed in the reference section in this paper.
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were in nursing homes any time in 2004. Previous studies
have demonstrated good reliability of MDS reported
diagnoses.22
For this analysis of comparison with the MDS
information, the use of the expert panel ICD code and
examination of up to 30 months of data to detect
dementia diagnosis were kept constant in the dementia
patient selection criteria. For the selection criteria
involving number of occurrences of dementia-related
claims, most of the published studies using medical
claims data required only one occurrence of a dementia-
related claim as a criterion to identify patients with
dementia.1,2,10–12,16 One Medicare study required at least
2 occurrences of dementia-related claims suggesting that
this method would increase specificity of identification of
dementia patients.20 However, the use of 2 or more
dementia-related claims has a potential to result in
exclusion of patients with a single claim because of a
new, though perhaps valid diagnosis.20 As a result,
specificity, sensitivity, accuracy, negative predictive value,
and positive predictive value were compared using 1 or
more dementia-related claims and using 2 or more
dementia-related claims as criteria. Comparisons also
were made among individuals age 40 years or older and
individuals age 60 years or older.
Prevalence Estimates of Diagnosed Dementia in
Indiana Medicaid Population
Age-specific prevalence estimates of diagnosed
dementia were calculated for individuals of age 40 years
old to 90 years old in age increments of 5 years and for
various age thresholds including 40 years or older, 50
years or older, 60 years or older, 70 years or older, 80
years or older, and 90 years or older.
Comparison of Prevalence Estimates With
Previous Studies in the Medicaid Population
To compare differences in estimates of prevalence of
diagnosed dementia over 10 years, estimates also were
calculated using dementia patient selection criteria from
previous studies of the Georgia Medicaid2 and the
California Medicaid populations.1 We constructed 95%
confidence intervals to assess differences in sex, race,
Medicaid eligibility categories, and proportions that were
dual Medicare and Medicaid eligible in the diagnosed




Among all 2004 Indiana Medicaid beneficiaries,
17% were 40 years or older, 12% were 50 years or older,
and 9% were 60 years or older. Among beneficiaries that
were 40 years or older, approximately 66% were women,
76% were white, and 62% were dual Medicare and
Medicaid eligible. Approximately, 24% of Indiana
Medicaid beneficiaries 40 years or older received nur-
sing-facility care some time in 2004.
Evaluation of the Effect of Patient Selection
Criteria on Estimates of Prevalence of
Diagnosed Dementia
Age-specific prevalence estimates of diagnosed
dementia using different combinations of ICD code sets,
number of occurrences of dementia-related claims, and
months of data used are shown in Table 2. The Table
shows the prevalence of diagnosed dementia among
individuals 40 years or older and individuals 60 years or
older, beginning from the most restrictive patient selec-
tion criteria using the expert panel ICD set, 2 or more
occurrences of dementia-related claims, and up to 12
months of data (baseline). The estimates varied substan-
tially by combination of criteria used. The prevalence
of diagnosed dementia among Indiana Medicaid bene-
ficiaries 40 years or older was 15.3% using the collective
ICD set, occurrence of 1 or more dementia-related claims,
and up to 30 months of data. However, the estimate in
the same age group dropped to 7.7% using the expert
panel ICD set, occurrence of 2 or more dementia-related
claims, and up to 12 months of data. The impact
of patient selection criteria on dementia prevalence
estimates was similar among Indiana Medicaid benefici-
aries 60 years or older, ranging from 14.5% to 26.6%.
When using the baseline criteria but changing the
interval of data examined from up to 12 months to up
to 30 months estimates increased from 7.7% to 9.5%
among 40 years or older and 14.5% to 17.9% among
60 years or older and when changing the ICD set used
from the expert panel ICD set to the collective ICD set,
estimates increased from 7.7% to 10.1% among 40 years
or older and from 14.5% to 18.5% among 60 years or
older (Table 2).
Specificity and Sensitivity of the Dementia
Patient Selection Criteria
Table 3 compares dementia classification on the
basis of the selected combination of patient selection
criteria for this study with MDS data on dementia
diagnosis. For both age strata examined, the patient
selection criteria was varied to assess specificity and
sensitivity when using 1 or more dementia-related claims
as compared with using 2 or more dementia-related
claims to identify patients. Dementia classification on the
basis of 1 or more dementia-related claims had higher
sensitivity, accuracy, and negative predictive value as
compared with dementia classification on the basis of 2 or
more dementia-related claims. Although dementia classi-
fication on the basis of 2 or more dementia-related claims
had slightly better specificity (88% vs. 85% among 40 y or
older and 87% vs. 84% among 60 y or older), the loss in
sensitivity with that approach compared with the use of
1 or more dementia-related claims was sizeable (63% vs.
69% among both the 40 y or older and the 60 y or older).
Overall accuracy was also higher using the criterion of
1 or more dementia-based claims rather than 2 or more
claims, that is, 77% vs. 76% for a sample including
persons 40 years or older and 76% versus 75% for a
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sample including persons 60 years or older. As a result,
occurrence of 1 or more dementia-related claims was
chosen as the patient selection criteria along with use of
the expert panel ICD set and up to 30 months of data for
identifying patients with dementia.
Age-specific Prevalence Estimates of Diagnosed
Dementia in Indiana
Using the expert panel ICD set, occurrence of 1 or
more dementia-related claims and up to 30 months of
data, the age-specific prevalence of diagnosed dementia
among Indiana Medicaid beneficiaries in 2004 was
estimated (Table 4). The estimated prevalence of diag-
nosed dementia in Indiana Medicaid were 10.9% for
individuals aged 40 years or older, 15.2% for individuals
50 years or older, and 20.3% for individuals 60 years or
older. The estimate of prevalence of diagnosed dementia
in the age group 40 to 44 years was 0.8%. Estimates of
prevalence of diagnosed dementia increased by a factor of
1.5 to 2 with 5-year increments in age from 60 to 64 years
to 80 to 84 years. The estimated prevalence of diagnosed
dementia was 38.2% among Indiana Medicaid benefici-
aries 90 years or older.
Characteristics of Patients With Dementia in
Indiana
In 2004, among Indiana Medicaid beneficiaries 40
years old or older with diagnosed dementia, 72% were
females, 86% were white, and 93% were dual Medicare
and Medicaid eligible. Approximately, 90% of indivi-
duals with dementia received care in a nursing facility at
some time in 2004.
Individuals with dementia often had multiple claims
with different diagnoses of dementia. Approximately,
49% of the individuals with dementia had at least 1 claim
with a diagnosis of senile dementia (ICD-9-CM codes:
290.0, 290.2, 290.20, 290.21, 290.3) and 49% of the
individuals had at least 1 claim with a diagnosis of
Alzheimer disease (ICD-9-CM code 331.0). Other diag-
noses among individuals with dementia included demen-
tia in condition classified elsewhere (ICD-9-CM code:
294.1, 294.10, 294.11) 28%, arteriosclerotic dementia
TABLE 3. Comparison of Dementia Classification Using Occurrence of 1 or More Dementia-related Claims and 2 or More
Dementia-related Claims With Dementia Diagnosis in the MDS
Dementia Based
Dementia in MDS





Dementia using 1 or more dementia-related claims*
40 y or older Yes 12,727 3037 15,764 85% 69% 77% 81% 74%
No 5824 16,950 22,774 — — — — —
Total 18,551 19,987 38,538 — — — — —
60y or older Yes 12,272 2597 14,869 84% 69% 76% 83% 71%
No 5637 13,604 19,241 — — — — —
Total 17,909 16,201 34,110 — — — — —
Dementia using 2 or more dementia-related claims*
40 y or older Yes 11,751 2357 14,108 88% 63% 76% 83% 72%
No 6800 17,630 24,430 — — — — —
Total 18,551 19,987 38,538 — — — — —
60y or older Yes 11,333 2036 13,369 87% 63% 75% 85% 68%
No 6576 14,165 20,741 — — — — —
Total 17,909 16,201 34,110 — — — — —
*The other patient selection criteria, that is, use of expert panel ICD set and up to 30mo of data were kept constant.
TABLE 2. Relationship Between Dementia-defining Criteria and Estimates of Prevalence of Dementia Among Indiana Medicaid
Beneficiaries
40 y or Older 60 y or Older









Baseline* 12,914 7.7 12,128 14.5
Collective ICD set 17,025 10.1 15,431 18.5
Occurrence of 1 or more claims 15,112 8.9 14,062 16.8
30mo of data 16,057 9.5 14,956 17.9
Collective ICD set and occurrence of 1 or more claims 20,419 12.1 18,112 21.7
Collective ICD set and 30mo of data 21,426 12.7 19,023 22.3
Occurrence of 1 or more claims and 30mo of data 18,439 10.9 16,969 20.3
Collective ICD set, occurrence of 1 or more claims and
30mo of data
25,765 15.3 22,209 26.6
*Baseline criteria was expert panel ICD set, occurrence of 2 or more dementia diagnosis and 12mo of data.
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(ICD-9-CM code: 290.4, 290.40, 290.41, 290.42, 290.43)
16%, and presenile dementia (ICD-9-CM code: 290.1,
290.10, 290.11, 290.12, 290.13) 10%.
Comparison of Prevalence Estimates With
Previous Studies in the Medicaid Population
To investigate whether the higher prevalence of
diagnosed dementia in this study as compared with
previous estimates was due to differences in selection
criteria used, estimates in Indiana were calculated based
on selection criteria used in a study of the 1994 prevalence
of diagnosed dementia in the Georgia Medicaid popula-
tion2 and on the basis of the criteria used in a study of the
1995 prevalence of diagnosed dementia in the California
Medicaid population1 (Table 5). Using the Georgia
Medicaid study criteria, which included use of selected
ICD codes (column B of Table 1), 1 or more occurrence
of dementia-related claims, and up to 12 months of data,
the prevalence of diagnosed dementia in Indiana was
13.1% among beneficiaries 50 years or older as compared
with 4.4% reported for that age group in the 1994
Georgia Medicaid study.2 Using the California Medicaid
study criteria that included use of selected ICD codes
(column A of Table 1), for 1 or more occurrences of
dementia-related claims, from up to 12 months of data,
the prevalence of diagnosed dementia in Indiana was
17.3% among beneficiaries 60 years or older as compared
with 4.1% reported for that age group in the 1995
California Medicaid study.1
The Georgia Medicaid diagnosed dementia popula-
tion and the California Medicaid diagnosed dementia
population were compared with the Indiana Medicaid
diagnosed dementia population on sex, race, Medicaid
eligibility category, and proportion that were dual Medi-
care and Medicaid eligible (Table 5). As indicated by the
nonoverlapping 95% confidence intervals for each variable,
the diagnosed dementia populations from Indiana and the
2 states differed significantly. The 2004 Indiana Medicaid
dementia population had higher proportions of whites and
individuals eligible in the aged category whereas there were
lower proportions of blacks, individuals eligible in the blind
or disabled category and individuals that were dual
TABLE 4. Age-specific Prevalence Estimate of Diagnosed
Dementia in 2004 in Indiana
Age No. Individuals*
No. Individuals
With Dementiaw Percent (%)
Prevalence by 5 y increments
40 to 44 y 27,710 218 0.8
45 to 49 y 22,724 302 1.3
50 to 54 y 18,287 379 2.1
55 to 59 y 16,075 571 3.6
60 to 64 y 14,648 723 4.9
65 to 69 y 14,183 992 7.0
70 to 74 y 12,420 1676 13.5
75 to 79 y 12,411 2821 22.7
80 to 84 y 12,063 3911 32.4
85 to 89 y 9454 3677 38.9
90 y and over 8302 3169 38.2
Prevalence by various minimum ages
40 y or older 168,277 18,439 10.9
50 y or older 117,843 17,919 15.2
60 y or older 83,481 16,969 20.3
70 y or older 54,650 15,254 27.9
80 y or older 29,819 10,757 36.1
90 y or older 8302 3169 38.2
*Medicaid beneficiaries that were eligible for at least 1mo in 2004.
wCriteria used to identify patients with dementia include the expert panel ICD
set, 1 or more occurrences of dementia-related claims and up to 30mo of data.
TABLE 5. Comparison of 2004 Prevalence of Dementia in Indiana Using Patient Selection Criteria Used by the Georgia Medicaid2
and the California Medicaid1 Studies
Indiana Data
Criteria GA Medicaid CA Medicaid* Using GA Criteriaw Using CA Criteriaw
Age Z50 y Z60 y Z50 y Z60 y
Year of data 1994 1995 2004 2004
Population 197,068 62,450 117,843 83,481
No. patients with dementia 8671 2575 15,383 14,425
Prevalence 4.4% 4.1% 13.1% 17.3%
% of dementia patient who
were females, (95% CI)
76.6% (75.5%-77.5%) 72.5% (70.8%-74.2%) 73.1% (72.4%-73.8%) 74.2% (73.5%-74.9%)
Race (95% CI)
White 69.3% (68.3%-70.3%) 64.8% (63.0%-66.6%) 85.6% (85.0%-86.2%) 85.5% (84.9%-86.1%)
Black 26.9% (26.0%-27.8%) 9.9% (8.7%-11.1%) 10.8% (10.3%-11.3%) 10.9% (10.4%-11.4%)
Hispanic 0.5% (0.4%-0.6%) 5.0% (4.2%-5.8%) 0.8% (0.7%-0.9%) 0.7% (0.6%-0.8%)
Medicaid eligibility category
(95% CI)
Aged 61.5% (60.5%-62.5%) 82.4% (80.9%-83.9%) 89.7% (89.2%-90.2%) 94.9% (94.5%-95.3%)
Disabled 13.3% (12.6%-14.0%) 15.2% (13.8%-16.6%) 3.7% (3.4%-4.0%) 1.8% (1.6%-2.0%)
Blind 17.9% (17.1%-18.7%) 1.7% (1.2%-(2.2%) 6.5% (6.1%-6.9%) 3.2% (2.9%-3.5%)
Other 5.2% (4.7%-5.7%) 0.7% (0.4%-1.0%) 0.1% (0.1%-0.1%) 0.1% (0.0%-0.2%)
% of dual Medicare and
Medicaid eligible (95% CI)
97.4% (97.1%-97.7%) 73.4% (71.4%-75.1%) 93.9% (93.5%-94.3%) 96.3% (96.0%-96.6%)
*The California Medicaid study used a 10% random sample of the California Medicaid data.
wPatient selection criteria included a list of ICD codes (for specific ICD codes refer to Columns A and B in Table 1), 1 or more occurrence of dementia-related claim and
use of 12mo of data.
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Medicare and Medicaid eligible as compared with the
Georgia Medicaid dementia population.
The 2004 Indiana Medicaid diagnosed dementia
population had higher proportions of whites, individuals
eligible in the aged category and individuals with dual
Medicare and Medicaid eligibility whereas there was a
lower proportion of individuals eligible in the disabled
category as compared with the California Medicaid
dementia population.
DISCUSSION
In 2004, the prevalence of diagnosed dementia
among Indiana Medicaid beneficiaries was estimated at
15.2% among individuals age 50 years or older and
20.3% among individuals age 60 years or older. This is a
marked difference from studies of the 1994 Georgia
Medicaid population2 and 1995 California Medicaid
population (3.5 times to 5 times higher).1 The current
diagnosed dementia prevalence estimates using the same
selection criteria as the Georgia Medicaid study2 and the
California Medicaid study1 still remained at 3 to 4 times
higher than the 1994 and 1995 estimates reported in those
studies.
A similar difference over time in estimated pre-
valence of diagnosed Alzheimer disease was identified in a
9-year longitudinal study of Medicare beneficiaries by
Taylor et al.15 The authors found a 2.5-fold increase in
cases identified with Alzheimer disease in 1999, when
compared with 1991. Multiple factors may be responsible
for the higher estimates of diagnosed dementia found in
the present study. The widespread availability of phar-
macologic agents for treatment of dementia since 1994
may have resulted in increased screening and evaluation
of dementia. Coverage of dementia in the public press and
media also may have prompted more attention to
diagnosis and subsequent coding of dementia. Some
Centers for Medicare and Medicaid Services (CMS)
policies such as Program Memorandum AB01-135
published in 2001 that discouraged Medicare contractors
from automatic denial of services for patients with
dementia based solely on ICD-9 codes and encouraged
specific coding for dementia also may have contributed to
increases in coding and subsequent increases in the
observed diagnosed dementia prevalence estimates.24
Selection of claims-based criteria for identifying
patients with dementia affected prevalence estimates by
nearly 100%. Prevalence estimates of diagnosed dementia
varied greatly across age strata. Each of the selection
criteria, including ICD codes used, the age threshold
used, minimum number of dementia-related claims used,
and months of data examined, had similar impact on
prevalence estimates. The estimates of diagnosed demen-
tia for individuals 40 years or older varied from 7.7% to
15.3%, whereas the estimates for individuals 60 years or
older varied from 14.5% to 26.6%, depending on the
selection criterion used.
Review of the literature on dementia-related ICD
codes used in previous studies showed wide variation in
ICD codes used across studies. This makes meaningful
comparison of findings across studies difficult or impos-
sible. Some studies have used ICD codes for unspecified
psychotic conditions1,2,10–14 and senility,1,2,10,13,15 to identi-
fy patients with dementia, though these terms themselves
do not denote dementia. Use of nonspecific ICD codes like
290 may have been appropriate in earlier studies due to
lower incentives for coding with 4-digit ICD codes than
currently exist. The current study generated a list of ICD
codes, the ‘‘expert panel ICD set’’ (a subset of the collective
ICD set obtained from review of previous studies) by
surveying a panel of health professionals with experience
evaluating or treating patients with dementia. The expert
panel ICD set contained a list of ICD codes that clinicians
perceived as specific for identifying patients with dementia.
The expert panel ICD set derived in this study may be
useful for other investigators as well in identifying patients
with dementia from administrative claims data.
The patient selection criteria used in this study which
included use of the expert panel ICD set, occurrence of 1 or
more dementia-related claims and up to 30 months of data,
had good specificity (85%), sensitivity (69%), and accuracy
(77%) when compared with MDS data. These levels of
agreement are comparable to previous published studies in
other therapy areas that have assessed agreement of case
ascertainment techniques on the basis of the medical claims
with medical records.25
Estimates of prevalence of diagnosed dementia are
important and have implications for resource allocation,
especially within Medicaid. Close to one-half of nursing-
home care expenditures are borne by the Medicaid
program.9 Nursing-home expenditures were estimated at
$115.4 billion in 2004.26 Previous studies have indicated
that the prevalence of dementia among nursing-home
residents at admission is approximately 50%.27
The study has several limitations. Claims data are
recorded for reimbursement and administration purposes
and are not likely to capture perfectly occurrences of a
disease. However, identification of individuals with
diagnosed disease from administrative claims data using
ICD codes is accepted and widely used in research. Our
comparison of dementia classification from claims with
MDS reported diagnoses provides greater confidence in
the estimates. Comparison between dementia classifica-
tions on the basis of the medical claims with MDS
reported diagnoses was possible only in a subset of
Medicaid beneficiaries that resided in nursing homes at
some time in 2004. Although limited to nursing home
patients, the analysis allowed for comparison with MDS
reported diagnosis which has been shown to have good
reliability.22 Data were not available to permit assessment
of the patient selection criteria for specificity and
sensitivity among the subset of the sample that had no
nursing home use in 2004.
All analyses in the study were conducted on
Medicaid beneficiaries that were eligible for at least 1
month in 2004. To determine the impact of months of
Medicaid eligibility in 2004 on estimates, the analyses
were repeated on a subset of Medicaid beneficiaries that
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were eligible for all 12 months of 2004. The impact of
changing the sample inclusion criteria to require Medi-
caid eligibility for all of 2004 did not change the pattern
of dependence of prevalence of diagnosed dementia on
patient selection criteria. The estimates of diagnosed
dementia, in the population of Medicaid beneficiaries
eligible for all of 2004, tended to be slightly higher (11.2%
vs. 10.9% among 40 y or older and 20.4% vs. 20.3%
among 60 y or older), indicating that Medicaid benefici-
aries with dementia were more likely to be eligible for all
of 2004.
Some of the differences in prevalence estimates of
diagnosed dementia across the states examined may be
explained by differences in the characteristics of the
Medicaid populations or differences in the general
populations in the states. Comparing 2003 Medicaid data
for each state, Georgia had a slightly higher proportion of
Medicaid beneficiaries 65 years or older (10%) as
compared with Indiana (8.6%) or California (8.7%).28
However, on the basis of the 2000 census data, Indiana
had a higher proportion of individuals of age 65 to 74
years (6.5%), 75 to 84 years (4.4%), and 85 years or older
(1.5%) as compared with Georgia (65 to 74 y—5.3%, 75
to 84 y—3.2%, 85 y or older—1.1%) or California (65 to
74 y—5.6%, 75 to 84 y—3.8%, 85 y or older—1.0%),
possibly explaining some of the higher estimated pre-
valence of diagnosed dementia observed in Indiana
compared with Georgia or California.29 The differences
observed in the dementia populations across the states
were consistent with the population make-up of each of
the states.30
In conclusion, the combination of the patient
selection criteria used in this study that included the
expert panel ICD set, 1 or more dementia-related claims,
and use of up to 30 months of data, provides a balance
between sensitivity and specificity in identifying patients
with dementia from medical claims. Using those criteria,
the estimate of prevalence of diagnosed dementia in the
Indiana Medicaid population among individuals 60 years
or older was 20.3% in 2004. The estimated prevalence of
diagnosed dementia among Medicaid beneficiaries is
more than 3 times estimates from a decade ago for other
Medicaid populations. Although a number of factors
including aging of the population, changes in ICD
coding, and better diagnosis of dementia may be
responsible for the increase, the estimates show the need
for increased allocation of resources for this disease.
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